2021 | 2020 Korean guidelines for the management of metastatic prostate cancer
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2013 | A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC) | LUNG CANCER |
2022 | ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model
| YONSEI MEDICAL JOURNAL |
2000 | Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment | Journal of Clinical Oncology |
2023 | Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments
| CANCERS |
2007 | Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2014 | Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study | ANNALS OF HEMATOLOGY |
2018 | Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma.
| YONSEI MEDICAL JOURNAL |
2020 | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
| SCIENTIFIC REPORTS |
2017 | Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation
| RADIATION ONCOLOGY JOURNAL |
2016 | Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation. | TECHNOLOGY IN CANCER RESEARCH & TREATMENT |
2008 | Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: A case report
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2019 | Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2004 | Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas | LEUKEMIA & LYMPHOMA |
2019 | Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization | Japanese Journal of Clinical Oncology |
2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| MEDICINE |
2012 | Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer. | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2013 | Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study
| RADIATION ONCOLOGY JOURNAL |
2009 | Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study
| JOURNAL OF CLINICAL ONCOLOGY |
2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | JOURNAL OF NEURO-ONCOLOGY |
2015 | Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience
| RADIATION ONCOLOGY JOURNAL |
2012 | Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors | ANNALS OF HEMATOLOGY |
2020 | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
| CANCER RESEARCH AND TREATMENT |
2020 | The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
| JOURNAL OF THORACIC DISEASE |
2014 | The role of radiotherapy in the management of POEMS syndrome.
| RADIATION ONCOLOGY |
2016 | The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.
| YONSEI MEDICAL JOURNAL |